All Articles

Treating over 100,000 patients in two years, a novel gel therapy is leading a paradigm shift in interventional dry eye management. Here's how.

A first-of-its-kind college launches a debt-free, on-the-job degree model to tackle the nation's critical shortage of healthcare professionals.

Transom Capital Group appoints Luke Dauch, a decade-long J.P. Morgan banker, to bolster its deal origination in a competitive middle-market landscape.

Belgian firm EDGX just put an AI brain in space. Its STERNA system promises to revolutionize data processing from orbit, with huge impacts on Earth.

Appknox launches AI co-pilot KnoxIQ to prioritize real exploits over static alerts, tackling the surge in vulnerabilities from AI-generated code.

A new non-profit has assembled leaders from Philips, Kearney, and more to standardize how companies navigate global volatility and integrate risk analysis.

The family-owned brand is bringing its creatine protein bar to GNC, betting on ultimate convenience to disrupt the traditional supplement market.

Sling is tackling the pilot shortage with an integrated ecosystem of advanced training and modern aircraft, on full display at Sun 'n Fun 2026.

A new report argues companies have the tools but lack the strategy, making organizational misalignment the top cybersecurity threat heading into 2026.

Karl Blackburn, former head of Quebec’s top employers’ council, takes the helm at the Montreal Heart Institute Foundation, signaling a new era.

Lodging Dynamics appoints 31-year veteran Kristie Byrd as CCO, launching an integrated commercial model to unify sales, marketing, and revenue strategy.

Nasdaq-listed Freedom Holding Corp. is considering a local stock offering in Kazakhstan, a strategic move to deepen its regional dominance and tap new capital.

In a novel proposal, IKE Tech asks the FDA to regulate its AI-powered compliance software, aiming to curb youth vaping with biometric and blockchain tech.

As Crocs sets its Q1 earnings call, all eyes are on the struggling HEYDUDE brand, contrasting with the core brand's strong international performance.

Eli Lilly's new once-daily oral GLP-1, Foundayo, is now on telehealth platform Ro, offering a convenient, needle-free alternative to injectable drugs.

A new program offers Northern California homeowners rebates and monthly payments to install home batteries, countering recent solar policy shifts.

Amid market volatility, NewPower Worldwide hires industry veteran Enda Ruddy to lead its strategic push for growth and resilience in the crucial EMEA region.

OncoC4 begins a landmark trial for ONC-841, a drug targeting immune cells in the brain, offering a new front in the fight against Alzheimer's disease.

AllRock Bio has begun a Phase 2a trial for its novel drug ROC-101, testing it in combination with new standard-of-care therapies for pulmonary hypertension.

Ease.io's annual awards highlight the leaders and technologies redefining factory excellence, from individual trailblazers to data-driven plant transformations.